Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

KRT14 anticorps (AA 351-472)

L’anticorps Souris Monoclonal anti-KRT14 a été validé pour IHC, FACS et IHC (fp). Il convient pour détecter KRT14 dans des échantillons de Humain, Rat, Souris et Porc.
N° du produit ABIN7655927

Aperçu rapide pour KRT14 anticorps (AA 351-472) (ABIN7655927)

Antigène

Voir toutes KRT14 Anticorps
KRT14 (Keratin 14 (KRT14))

Reactivité

  • 120
  • 74
  • 60
  • 15
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Rat, Souris, Porc

Hôte

  • 74
  • 50
  • 2
Souris

Clonalité

  • 65
  • 60
  • 1
Monoclonal

Conjugué

  • 74
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp KRT14 est non-conjugé

Application

  • 52
  • 52
  • 42
  • 33
  • 30
  • 17
  • 14
  • 13
  • 13
  • 12
  • 12
  • 10
  • 7
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

KRT14-2375
  • Épitope

    • 29
    • 15
    • 13
    • 10
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 351-472

    Fonction

    Cytokeratin 14 (KRT14) (Squamous Cell Marker)(KRT14/2375)

    Attributs du produit

    Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogène

    Recombinant human KRT14 fragment (around aa351-472)

    Isotype

    IgG2a, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    Positive Control: A431 or HeLa cells. Skin or Squamous Cell Carcinoma.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS, no BSA, no azide

    Agent conservateur

    Without preservative

    Stock

    -20 °C

    Stockage commentaire

    Stable at room temperature or 37°C for 7 days.

    Store at -20 °C. Protect fluorescent conjugates from light

    Date de péremption

    24 months
  • Antigène

    KRT14 (Keratin 14 (KRT14))

    Autre désignation

    Keratin 14

    Sujet

    Synonyms: CK-14, Dowling Meara, ebs3, ebs4, Epidermolysis Bullosa Simplex, k14, Keratin 14, Keratin Type I Cytoskeletal 14, Koebner, krt14, NFJ

    Gene Symbol: KRT14

    Tissue Expression: Epithelial cells

    Poids moléculaire

    ~50 kDa

    ID gène

    3861

    UniProt

    P02533
Vous êtes ici:
Chat with us!